Literature DB >> 19373236

The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients.

Yuji Shigematsu1, Sadako Norimatsu, Akiyoshi Ogimoto, Tomoaki Ohtsuka, Hideki Okayama, Jitsuo Higaki.   

Abstract

Left atrial (LA) enlargement is an early sign of hypertensive heart disease. Insulin resistance and obesity, integral components of metabolic syndrome, are closely associated with the development of hypertension. However, few echocardiographic studies have assessed the relations of insulin resistance and obesity to LA size in hypertensive patients. We enrolled 106 never-treated hypertensive patients (57 men and 49 women) to assess the possible relations of insulin resistance and obesity to LA size. Insulin resistance was estimated using the homeostasis model assessment (HOMA) formula. Echocardiographically determined LA dimension, left ventricular (LV) mass and relative wall thickness (RWT) were measured as markers of LA size, LV hypertrophy and LV geometry. The E/A ratio estimated by transmitral flow velocity was measured as a marker of LV diastolic function. In addition, body mass index (BMI) was calculated as weight (kg) divided by height (m)(2) as a marker of obesity. Multivariable regression analyses showed that BMI was the strongest independent predictor of LA size (P<0.0001), followed by the HOMA value (P=0.0003). However, LV mass, RWT and the E/A ratio did not bear significant relations to LA size. There were no sex-specific differences in the relations of HOMA value or BMI to LA size. In conclusion, LA size is influenced by insulin resistance and obesity, integral components of the metabolic syndrome, independently of LV hypertrophy, LV geometry or LV diastolic function in nondiabetic Japanese hypertensive patients.

Entities:  

Mesh:

Year:  2009        PMID: 19373236     DOI: 10.1038/hr.2009.41

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

Review 1.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

2.  Left atrial enlargement and blood pressure variability in untreated hypertensive patients.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2016-05-19       Impact factor: 3.872

3.  HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation.

Authors:  Z-H Lu; N Liu; R Bai; Y Yao; S-N Li; R-H Yu; C-H Sang; R-B Tang; D-Y Long; X Du; J-Z Dong; C-S Ma
Journal:  Herz       Date:  2014-10-23       Impact factor: 1.443

4.  Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients.

Authors:  Franco Cipollini; Enrica Arcangeli; Giuseppe Seghieri
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872

5.  Left ventricular extracellular volume fraction and atrioventricular interaction in hypertension.

Authors:  Jonathan C L Rodrigues; Tamas Erdei; Amardeep Ghosh Dastidar; Gergley Szantho; Amy E Burchell; Laura E K Ratcliffe; Emma C Hart; Angus K Nightingale; Julian F R Paton; Nathan E Manghat; Mark C K Hamilton
Journal:  Eur Radiol       Date:  2018-09-19       Impact factor: 5.315

Review 6.  Contributions to Hypertension Public Policy and Clinical Practice: A Review of Recent Reports.

Authors:  Michael A Weber; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-20       Impact factor: 3.738

7.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

8.  A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis.

Authors:  Tai-Hua Chiu; Hui-Ju Tsai; Hsin-Ying Clair Chiou; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  Left atrial enlargement in the early stage of hypertensive heart disease: a common but ignored condition.

Authors:  Guanhua Su; Heng Cao; Sudan Xu; Yongxin Lu; Xinxin Shuai; Yufei Sun; Yuhua Liao; Jingdong Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738

10.  Prevalence of left atrial enlargement and its risk factors in general Chinese population.

Authors:  Qiaoyun Ou; Yintao Chen; Shasha Yu; Xiaofan Guo; Huijie Zhao; Yingxian Sun
Journal:  BMC Cardiovasc Disord       Date:  2016-03-05       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.